EVAOLD
2026
Evaluation of a Strategy Guided by Imaging Versus Systematic Coronary Angiography in Elderly Patients With Ischemia: a Multicentric Randomized Non Inferiority Trial (EVAOLD)
In 587 patients aged 80 years or over with NSTEMI, a selective invasive strategy guided by stress imaging was not non-inferior to routine invasive management for death, myocardial infarction or stroke at 12 months.
Résultat
Efficacité: MACCE (all-cause death, non-fatal myocardial infarction, non-fatal stroke) at 12 monthsHR 1,22 (IC à 95 % 0,86-1,72) · P = 0,27
En dessous de 1 en faveur de a selective invasive strategy guided by stress imaging, au-dessus de 1 en faveur de routine invasive management.
- Différence absolue
- 3,4 points
La différence absolue est dérivée des taux d’événements.
Également rapporté: Recruitment stopped for futility after 587 of the planned 1,756 patients. Death, myocardial infarction or stroke at one year occurred in , so non-inferiority was not shown. The selective strategy did reduce the number of angiograms and their attendant complications.
- Sous-thème
- Elderly NSTEMI strategy
- Schéma
- Multicentre (France), open-label, 1:1 randomised, two-arm parallel non-inferiority trial; 12-month follow-up; non-inferiority declared if the upper limit of the one-sided 97.5% CI for the hazard ratio is <1.24 (7% absolute margin); registry status "terminated" after a planned interim analysis
- Pertinence
- Important: l’un des piliers parmi d’autres.
- Source
- Barone-Rochette G, et al. Presented at ESC Congress 2026, Hot Line 11, 31 August.
Discussion et critique
Sparing the very old an angiogram is an attractive idea and this trial could not show it is safe: the point estimate ran the wrong way, the confidence interval reached 1.72, and the data monitors stopped enrolment at a third of target for futility. That is not proof of harm: 587 patients and 130-odd events leave room for a smaller difference either way, but it removes the argument that stress imaging first is a defensible default at 80 and over. What the strategy did buy is fewer catheterisations; whoever wants to trade procedures for a possible excess of events now has to say so explicitly.